Advertisement

Topics

Johnson & Johnson-Aktie: Portfolioanpassung schreitet voran - Neues Kursziel

07:17 EDT 14 Jun 2018 | FinanzNachrichten

Frankfurt (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Aktienanalyst Bernhard Weininger von Independent Research: Bernhard Weininger, Aktienanalyst von Independent Research, senkt in ...

Original Article: Johnson & Johnson-Aktie: Portfolioanpassung schreitet voran - Neues Kursziel

NEXT ARTICLE

More From BioPortfolio on "Johnson & Johnson-Aktie: Portfolioanpassung schreitet voran - Neues Kursziel"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...